ﻻ يوجد ملخص باللغة العربية
DNA-encoded library (DEL) screening and quantitative structure-activity relationship (QSAR) modeling are two techniques used in drug discovery to find small molecules that bind a protein target. Applying QSAR modeling to DEL data can facilitate the selection of compounds for off-DNA synthesis and evaluation. Such a combined approach has been shown recently by training binary classifiers to learn DEL enrichments of aggregated disynthons to accommodate the sparse and noisy nature of DEL data. However, a binary classifier cannot distinguish between different levels of enrichment, and information is potentially lost during disynthon aggregation. Here, we demonstrate a regression approach to learning DEL enrichments of individual molecules using a custom negative log-likelihood loss function that effectively denoises DEL data and introduces opportunities for visualization of learned structure-activity relationships (SAR). Our approach explicitly models the Poisson statistics of the sequencing process used in the DEL experimental workflow under a frequentist view. We illustrate this approach on a dataset of 108k compounds screened against CAIX, and a dataset of 5.7M compounds screened against sEH and SIRT2. Due to the treatment of uncertainty in the data through the negative log-likelihood loss function, the models can ignore low-confidence outliers. While our approach does not demonstrate a benefit for extrapolation to novel structures, we expect our denoising and visualization pipeline to be useful in identifying SAR trends and enriched pharmacophores in DEL data. Further, this approach to uncertainty-aware regression is applicable to other sparse or noisy datasets where the nature of stochasticity is known or can be modeled; in particular, the Poisson enrichment ratio metric we use can apply to other settings that compare sequencing count data between two experimental conditions.
Uncertainty is the only certainty there is. Modeling data uncertainty is essential for regression, especially in unconstrained settings. Traditionally the direct regression formulation is considered and the uncertainty is modeled by modifying the out
COVID-19 pandemic has created an extreme pressure on the global healthcare services. Fast, reliable and early clinical assessment of the severity of the disease can help in allocating and prioritizing resources to reduce mortality. In order to study
COVID-19 pandemic is severely impacting the lives of billions across the globe. Even after taking massive protective measures like nation-wide lockdowns, discontinuation of international flight services, rigorous testing etc., the infection spreading
Objectives: Most cancer data sources lack information on metastatic recurrence. Electronic medical records (EMRs) and population-based cancer registries contain complementary information on cancer treatment and outcomes, yet are rarely used synergist
Several neural-based metrics have been recently proposed to evaluate machine translation quality. However, all of them resort to point estimates, which provide limited information at segment level. This is made worse as they are trained on noisy, bia